Incremental Impact of Adding Boys to Current Human Papillomavirus Vaccination Programs: Role of Herd Immunity
- 1 August 2011
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 204 (3) , 372-376
Abstract
(See the editorial commentary by Castle and Zhao, on pages 335–7.)Keywords
This publication has 12 references indexed in Scilit:
- Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in MalesNew England Journal of Medicine, 2011
- Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance dataThe Lancet Infectious Diseases, 2011
- Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysisVaccine, 2010
- Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United StatesBMJ, 2009
- Economic Evaluation of Human Papillomavirus Vaccination in Developed CountriesPublic Health Genomics, 2009
- Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta‐analysisInternational Journal of Cancer, 2009
- Epidemiology of Human Papillomavirus Infection in Men, Cancers other than Cervical and Benign ConditionsVaccine, 2008
- Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 diseaseVaccine, 2006
- Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic ReviewCancer Epidemiology, Biomarkers & Prevention, 2005
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003